Fig. 1From: Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter studyImpact of reduction in infusion time and/or dilution volume on (a) quality of life; (b) comfort during infusion; (c) concern about onset of adverse events, and (d) effect of lack of premedication drugs in the protocol on concern about the onset of adverse reactionsBack to article page